Fusion Antibodies plc announced that Sonya Ferguson, Non-executive Director, will not be seeking re-election at the AGM to be held on 27 October 2023, as she has decided to pursue another business opportunity. She will cease to be a Director of the Company at the close of the AGM.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.845 GBX | +4.20% | +11.45% | -9.53% |
Apr. 30 | EARNINGS AND TRADING: Software Circle & Beximco report higher revenue | AN |
Apr. 15 | Fusion Antibodies inks commercial contract for OptiPhage library | AN |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-9.53% | 4.48M | |
+64.23% | 62.59B | |
-2.31% | 41.18B | |
+45.21% | 40.29B | |
-8.29% | 27.9B | |
+11.97% | 26.21B | |
-21.16% | 19.09B | |
+7.54% | 13.08B | |
+27.17% | 12.05B | |
+25.72% | 12.26B |
- Stock Market
- Equities
- FAB Stock
- News Fusion Antibodies plc
- Fusion Antibodies plc Announces Sonya Ferguson, Non-Executive Director, Will Not Be Seeking Re-Election At the AGM